Andreas Guenther (Giessen, Germany), Carlo Albera (Orbassano (TO), Italy), Aikaterini D. Samara (Athens, Greece), Juergen Behr (Munich, Germany)
Interaction between mitochondrial ROS and ER stress on PHMG-induced pulmonary fibrosis
Yong Chul Lee (Jeonju, Republic of Korea), Yong Chul Lee, So Ri Kim, Dong Im Kim, Soon Ha Kim
|   |
CHI-91040, a novel inhaled p38α inhibitor, counteracts lung inflammation induced by IL-1β in the rat
Cataldo Martucci (Parma, Italy), Cataldo Martucci, Annalisa Murgo, Valentina Bagnacani, Giancarlo Aquino, Mary Fitzgerlad, Hanry Finch, Craig Fox, Chiara Carnini, Riccardo Patacchini, Maurizio Civelli, Gino Villetti
| |
Mesenchymal stem cells isolated from fibrotic human lung tissue inhibit collagen expression by lung fibroblasts
Katrin Esther Hostettler (Basel, Switzerland), Petra Khan, Amiq Gazdhar, Spasenija Savic, Michael Tamm, Didier Lardinois, Michael Roth, Thomas Geiser, Katrin Esther Hostettler
| |
Phenotype heterogeneity in a familial "brain lung thyroid syndrome" related to a novel NKX-2.1 mutation
Nadia Nathan (Paris, France), Nadia Nathan, Raphaël Borie, Sophie Jovien, Diane Doummar, Malek Louha, Julie Beucher, Mélanie Henriat, Estelle Breton, Annick Clement
| |
IL-6 and IL-8 in stable and exacerbated IPF patients and their association to outcome
Ioannis Tomos (Alimos, Greece), Ioannis Tomos, Effrosyni Manali, Anna Karakatsani, Aris Spathis, Ioanna Korbila, Antonis Analitis, Petros Karakitsos, Spyros Papiris
| |
Role of dendritic cells in pulmonary fibrosis in mice
Meritxell Tort Tarrés (Hannover, Germany), Meritxell Tort Tarrés, Regina Maus, Jennifer Stolper, Franziska Aschenbrenner, Tobias Welte, Jack Gauldie, Martin Kolb, Ulrich A. Maus
| |
mRNA expression of YY1, TNF-α a TGF-β in lung samples gained by transbronchial biopsies (TBB) in patients with different interstitial lung diseases (ILDs)
Peter Paluch (Prague, Czech Republic), Peter Paluch, Martina Kolbekova, Martina Sterclova, Ondrej Viklicky, Irena Brabcova, Jelena Skibova, Martina Vasakova
| |
Targetingpyruvate kinase M2 isoform inhibits proliferation of human lung fibroblasts
Ellen Forty (London, United Kingdom), Ellen Forty, Paul Mercer, Dimitrios Anastasiou, Rachel Chambers
| |
Circulating monocytes from interstitial lung disease patients show an activated phenotype
Flavia Greiffo (Munich, Germany), Flavia Greiffo, Isis Fernandez, Marion Frankenberger, Jürgen Behr, Oliver Eickelberg
| |
Cytofluorimetric BAL cells characterization in IPF and in other ILD
Ermanno Puxeddu (Rome, Italy), Ermanno Puxeddu, Daniela Fraboni, Floriana Bardaro, Francesco Buccisano, Gabriella Lucà, Paola Rogliani
| |
Evaluation of laryngopharyngeal reflux in patients with interstitial lung disease (ILD) by a pharyngeal pH-probe
Eva Brunnemer (Heidelberg, Germany), Eva Brunnemer, Ute Oltmanns, Stella Piel, Felix Herth, Michael Kreuter
| |
Correlation of high resolution CT patterns to pulmonary function tests in patients with interstitial lung diseases
Khaled Hussein (Assiut, Egypt), Khaled Hussein, Lamiaa Shaban, Ehab Mohamed
| |
Clinical characteristics of patients with Idiopathic pulmonary fibrosis in a tertiary care center of a developing country
M Sajjad Sarwar (Karachi, Pakistan), M. Sajjad Sarwar, Ali B.S. Zubairi, Muhammad Irfan, Talha Shahzad, Aamir Abbas
| |
Investigation of KL-6 levels in patients with IPF- OSA overlap syndrome: Preliminary results
Katerina Antoniou (Heraklion, Crete, Greece), Stylianos Michelakis, Eliza Tsitoura, Izoldi Bouloukaki, Violeta Moniaki, Niki Malliaraki, Giorgos Papadogiannis, Stavroula Varda, Dimitrios Georgopoulos, Nikos Tzanakis, Sophia E. Schiza, Katerina Antoniou
| |
The physical and psychological needs of patients with idiopathic pulmonary fibrosis
Tim Sutherland (Leeds, United Kingdom), Tim Sutherland, Paul Beirne, Ann Boardman, Alison Boland, Susie Gillon, Jane Slough
| |
Health care system resource utilisation in patients with idiopathic pulmonary fibrosis
Sarah Szardien (Freckenfeld, Germany), Sarah Szardien, Boglarka Szentes, Sabine Witt, Eva Brunnemer, Larissa Schwarzkopf, Beate Schaufler, Felix Herth, Michael Kreuter
| |
End-of-life care in in-patients dying from pulmonary fibrosis
Beth Turnpenny (Bolton, United Kingdom), Beth Turnpenny, Jordan Sudworth, Alexander Gallagher, Jenny Wiseman, Abdul Ashish
| |
Interims analysis of the EXCITING-ILD registry (registry for exploring clinical and epidemiological characteristics of interstitial lung diseases)
Michael Kreuter (Heidelberg, Germany), Michael Kreuter, Felix J.F. Herth, Margarethe Wacker, Peter Hammerl, Conrad Wiederhold, Reiner Leidl, Andreas Hellmann, Michael Pfeifer, Jürgen Behr, Sabine Witt, Dagmar Kauschka, Marcus Mall, Andreas Günther, Philip Markart
| |